Regressive DOTA labelling performance with indium-111 and yttrium-90 over a week of use.
Hainsworth
James E S
JE
Mather
Stephen J
SJ
D004355:Drug Stability; D006573:Heterocyclic Compounds, 1-Ring / Q000032:analysis / Q000737:chemistry*; D006851:Hydrochloric Acid / Q000737:chemistry*; D007205:Indium Radioisotopes / Q000032:analysis / Q000737:chemistry*; D007553:Isotope Labeling / Q000379:methods*; D019275:Radiopharmaceuticals / Q000032:analysis / Q000737:chemistry; D015021:Yttrium Radioisotopes / Q000032:analysis / Q000737:chemistry*
D006573:Heterocyclic Compounds, 1-Ring; D007205:Indium Radioisotopes; D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes; C071349:1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid; D006851:Hydrochloric Acid